bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: J J M A M F J
2013: D N O S A J

 
  Other news for:
Hormone Replacement Therapy
Menopause
Postmenopause
 Resources from HONselect
For Many Women, Hot Flashes Last 10 Years or More After Menopause
Obese white women and black women most prone to the condition, study finds

By Robert Preidt

FRIDAY, Jan. 31, 2014 (HealthDay News) -- Many women continue to have hot flashes for years after menopause, a new study finds.

Researchers looked at 255 older women and found that 80 percent of them had moderate-to-severe hot flashes during menopause, 17 percent had mild hot flashes and 3 percent had no hot flashes.

Obese white women and black women (whether obese or not) were most likely to have moderate-to-severe hot flashes, while non-obese white women had the lowest risk. Women who had more than a high school education had a 34 percent lower risk of hot flashes, a finding that calls for additional study, the University of Pennsylvania Perelman School of Medicine researchers said.

They also found that moderate-to-severe hot flashes continued for an average of nearly five years after menopause. And more than one-third of women had moderate-to-severe hot flashes for 10 years or more after menopause, according to the study published online this week in the journal Menopause.

Hormone replacement therapy is the primary medical treatment for hot flashes, according to the researchers. Current guidelines recommend that the treatment be used for no longer than five years. But the Penn researchers said there's a lack of evidence to support the recommended three- to five-year limits on the use of hormone therapy.

They noted that concerns about health issues linked to hormone therapy -- such as cancer and cardiovascular problems -- make some doctors reluctant to prescribe it, or they stick to the recommended time limits on its use.

"Our findings point to the importance of individualized treatments that take into account each woman's risks and benefits when selecting hormone or non-hormone therapy for menopausal symptoms," study author Ellen Freeman, a research professor in the department of obstetrics and gynecology, said in a university news release.

"While leading non-hormone therapies such as Paxil or Escitalopram may provide some relief of menopausal symptoms for some women, for others, they may not be as effective as hormone-based therapy," she added.

More information

The U.S. Office on Women's Health has more about menopause.

SOURCE: University of Pennsylvania, news release, Jan. 30, 2014

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=684419

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Women
Hot Flashes
Hormones
Research Personnel
Therapeutics
Risk
Hormone Replacement Therapy
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact